Applied use of venovenous extracorporeal membrane oxygenation support in
severe septic shock and sepsis induced cardiomyopathy with unknown
etiology pneumonia: a case report
Abstract
BACKGROUD: There is no consensus over the effect of V-V ECMO on septic
patients with sepsis-induced cardiomyopathy. CASE PRESENTATION: A
48-year-old male was transferred to our emergency department for
acute-onset fever lasting for four days on November 1, 2019. He traveled
in many places in northern China (Yan’an, Beijing, Qinhuangdao and so
on) one month prior to admission. We initiated V-V ECMO on day 2. The
patient’s hemodynamics and infection condition improved. After detecting
of nasopharyngeal swabs and bronchoalveolar lavage samples, A/H1N1
influenza, influenza B, coronavirus, System Inflammatory Reaction
Syndrome (SIRS), Middle East respiratory syndrome (MERS) and other
epidemic disease were ruled out. On the day 22, patient’s pulmonary
images findings revealed the recover. He was transferred to a regular
room discharged soon. CONCLUSION: The outcome of our patient shows that
V-V ECMO may also benefit the patient when managing septic shock and
septic cardiomyopathy.